Journal of the Neurological Sciences
Volume 288, Issue 1 , Pages 129-134 , 15 January 2010

Putaminal volume and diffusion in early familial Creutzfeldt–Jakob Disease

  • Ilana Seror

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, P.O. Box 1230, One Gustave Levy Place, New York, NY 10029, USA
    • ,
  • Hedok Lee

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, P.O. Box 1230, One Gustave Levy Place, New York, NY 10029, USA
    • ,
  • Oren S. Cohen

      Affiliations

    • Department of Neurology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Chen Hoffmann

      Affiliations

    • Department of Radiology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Isak Prohovnik

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, P.O. Box 1230, One Gustave Levy Place, New York, NY 10029, USA
    • Department of Radiology, Mount Sinai School of Medicine, P.O. Box 1230, One Gustave Levy Place, New York, NY 10029, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Mount Sinai Medical Center, P.O. Box 1230, One Gustave Levy Place, New York, NY 10029, United States. Tel.: +1 718 584 9000x3629.

Received 2 March 2009 ,Revised 17 August 2009 ,Accepted 22 September 2009.

References 

  1. Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–13383
  2. Jakob A. Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomichen Befunde. Z Gesamte Neurol Psychiatr. 1921;64:147–228
  3. Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol. 2008;64:97–108
  4. Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I. MR imaging of familial Creutzfeldt–Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol. 2008;29:1638–1643
  5. Gertz HJ, Henkes H, Cervos-Navarro J. Creutzfeldt–Jakob disease: correlation of MRI and neuropathologic findings. Neurology. 1988;38:1481–1482
  6. Barboriak DP, Provenzale JM, Boyko OB. MR diagnosis of Creutzfeldt–Jakob disease: significance of high signal intensity of the basal ganglia. AJR Am J Roentgenol. 1994;162:137–140
  7. Bahn MM, Kido DK, Lin W, Pearlman AL. Brain magnetic resonance diffusion abnormalities in Creutzfeldt–Jakob disease. Arch Neurol. 1997;54:1411–1415
  8. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease. Neurology. 2004;63:443–449
  9. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt–Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26:1551–1562
  10. Tschampa HJ, Kallenberg K, Urbach H, Meissner B, Nicolay C, Kretzschmar HA, et al. MRI in the diagnosis of sporadic Creutzfeldt–Jakob disease: a study on inter-observer agreement. Brain. 2005;128:2026–2033
  11. Lee H, Rosenmann H, Chapman J, Kingsley PB, Hoffmann C, Cohen OS, et al. Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. Brain. 2009;
  12. Lee H, Hoffmann C, Kingsley PB, Degnan A, Cohen OS, Prohovnik I. Enhanced Detection of Diffusion Reductions in Creutzfeldt–Jakob Disease at higher b-factor. AJNR Am J Neuroradiol in Press.
  13. Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD. Human growth hormone-related iatrogenic Creutzfeldt–Jakob disease with abnormal imaging. Arch Neurol. 2006;63:288–290
  14. Poon MA, Stuckey S, Storey E. MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt–Jakob disease. Neuroradiology. 2001;43:746–749
  15. Cohen OS, Hoffmann C, Lee H, Chapman J, Fulbright RK, Prohovnik I. MRI detection of the cerebellar syndrome in Creutzfeldt–Jakob disease. Cerebellum. 2009;
  16. Tisserand DJ, Pruessner JC, Sanz Arigita EJ, van Boxtel MP, Evans AC, Jolles et al. J. Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. Neuroimage. 2002;17:657–669
  17. Snook L, Plewes C, Beaulieu C. Voxel based versus region of interest analysis in diffusion tensor imaging of neurodevelopment. Neuroimage. 2007;34:243–252
  18. Pitiot A, Delingette H, Thompson PM, Ayache N. Expert knowledge-guided segmentation system for brain MRI. Neuroimage. 2004;23(Suppl 1):S85–96
  19. Xia Y, Bettinger K, Shen L, Reiss AL. Automatic segmentation of the caudate nucleus from human brain MR images. IEEE Trans Med Imaging. 2007;26:509–517
  20. Chupin M, Mukuna-Bantumbakulu AR, Hasboun D, Bardinet E, Baillet S, Kinkingnehun S, et al. Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: method and validation on controls and patients with Alzheimer's disease. Neuroimage. 2007;34:996–1019
  21. Yang J, Duncan JS. 3D image segmentation of deformable objects with joint shape-intensity prior models using level sets. Med Image Anal. 2004;8:285–294
  22. Shen D, Moffat S, Resnick SM, Davatzikos C. Measuring size and shape of the hippocampus in MR images using a deformable shape model. Neuroimage. 2002;15:422–434
  23. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–355
  24. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage. 2004;23(Suppl 1):S69–84
  25. Patenaude B, Smith S, Kennedy D, Jenkinson M, paper presented at the Human Brain Mapping Conference, Chicago, IL, USA 2007.
  26. “Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: Emerging and Other Communicable Diseases, Surveillance and Control.” (World Health Organization, 1998).
  27. Chapman J, Cohen O, Nitzan Z, Tsabari R, Prohovnik I. The CJD rating scale: a new tool for evaluation of neurologic symptomatology in early CJD patients. Neurology. 2007;68:A141
  28. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  29. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–155
  30. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys. 1965;42:288–292
  31. Lucerna S. In vivo atlas of deep brain structures. Springer-Verlag; 2002;pp
  32. Brian P, Smith S, Kennedy D, Jenkinson M. FIRST — FMRIB's integrated registration and segmentation tool. Human Brain Mapping Conference; 2007;
  33. Brian P, Smith S, Kennedy D, Jenkinson M. Improved surface models for FIRST. Human Brain Mapping Conference; 2008;
  34. Wilde EA, Bigler ED, Hunter JV, Fearing MA, Scheibel RS, Newsome MR, et al. Hippocampus, amygdala, and basal ganglia morphometrics in children after moderate-to-severe traumatic brain injury. Dev Med Child Neurol. 2007;49:294–299
  35. DelBello MP, Zimmerman ME, Mills NP, Getz GE, Strakowski SM. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord. 2004;6:43–52
  36. Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, et al. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res. 2007;154:199–208
  37. Ahsan RL, Allom R, Gousias IS, Habib H, Turkheimer FE, Free S, et al. Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus. Neuroimage. 2007;38:261–270
  38. Barkataki I, Kumari V, Das M, Taylor P, Sharma T. Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder. Behav Brain Res. 2006;169:239–247
  39. Brambilla P, Harenski K, Nicoletti MA, Mallinger AG, Frank E, Kupfer DJ, et al. Anatomical MRI study of basal ganglia in bipolar disorder patients. Psychiatry Res. 2001;106:65–80
  40. Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, et al. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res. 2003;124:129–140
  41. Binkofski F, Reetz K, Gaser C, Hilker R, Hagenah J, Hedrich K, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology. 2007;69:842–850
  42. Gunning-Dixon FM, Head D, McQuain J, Acker JD, Raz N. Differential aging of the human striatum: a prospective MR imaging study. AJNR Am J Neuroradiol. 1998;19:1501–1507
  43. Parashos IA, Tupler LA, Blitchington T, Krishnan KR. Magnetic-resonance morphometry in patients with major depression. Psychiatry Res. 1998;84:7–15
  44. Geng DY, Li YX, Zee CS. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery. 2006;58:256–262discussion 256–262
  45. Greenberg DL, Payne ME, MacFall JR, Provenzale JM, Steffens DC, Krishnan RR. Differences in brain volumes among males and female hormone-therapy users and nonusers. Psychiatry Res. 2006;147:127–134
  46. Russmann H, Vingerhoets F, Miklossy J, Maeder P, Glatzel M, Aguzzi A, et al. Sporadic Creutzfeldt–Jakob disease: a comparison of pathological findings and diffusion weighted imaging. J Neurol. 2005;252:338–342
  47. Tschampa HJ, Murtz P, Flacke S, Paus S, Schild HH, Urbach H. Thalamic involvement in sporadic Creutzfeldt–Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol. 2003;24:908–915
  48. Lin YR, Young GS, Chen NK, Dillon WP, Wong S. Creutzfeldt–jakob disease involvement of rolandic cortex: a quantitative apparent diffusion coefficient evaluation. AJNR Am J Neuroradiol. 2006;27:1755–1759
  49. Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S. Conspicuity and evolution of lesions in Creutzfeldt–Jakob disease at diffusion-weighted imaging. AJNR Am J Neuroradiol. 2002;23:1164–1172
  50. Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, Jager HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry. 2007;78:664–670
  51. Ukisu R, Kushihashi T, Kitanosono T, Fujisawa H, Takenaka H, Ohgiya Y, et al. Serial diffusion-weighted MRI of Creutzfeldt–Jakob disease. AJR Am J Roentgenol. 2005;184:560–566
  52. Geschwind MD, Potter CA, Sattavat M, Garcia PA, Rosen HJ, Miller BL, et al. Correlating DWI MRI with pathologic and other features of Jakob–Creutzfeldt disease. Alzheimer Dis Assoc Disord. 2009;23:82–87
  53. Manners DN, Parchi P, Tonon C, Capellari S, Strammiello R, Testa C, et al. Pathologic correlates of diffusion MRI changes in Creutzfeldt–Jakob disease. Neurology. 2009;72:1425–1431
  54. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt–Jakob disease. Arch Neurol. 2002;59:128–134
  55. Morey RA, Petty CM, Xu Y, Pannu Hayes J, Wagner HR, Lewis DV, et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage. 2008;
  56. Shen D, Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging. 2002;21:1421–1439
  57. Tae WS, Kim SS, Lee KU, Nam EC, Kim KW. Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder. Neuroradiology. 2008;50:569–581

PII: S0022-510X(09)00862-4

doi: 10.1016/j.jns.2009.09.019

Journal of the Neurological Sciences
Volume 288, Issue 1 , Pages 129-134 , 15 January 2010

Article Tools

* Image Usage & Resolution